A group of international scientists have mapped the genetic, cellular, and structural makeup of the human brain and the nonhuman primate brain, allowing for a deeper knowledge of the cellular basis of brain function and dysfunction, helping pave the way for a new generation of precision therapeutics for people with mental disorders and other disorders of the brain.
Source: nimh

Ketamine. For some people with treatment-resistant depression, this experimental therapy proved to be more than just life-changing—it was lifesaving. But how did a drug once used as a battlefield anesthetic evolve into esketamine, a treatment for major depressive illnesses? In this episode, we'll talk with Dr. Carlos Zarate Jr., who helped lay the groundwork for esketamine for treatment-resistant depression. We'll learn the history behind the development of esketamine, how it can help with depression, and what the future holds for this innovative line of clinical research.
Source: nimh

This pre-application webinar is for prospective applicants of RFA-MH-24-100: Precision HIV Health: Integrating Data and Implementation Science to Accelerate HIV Prevention and Treatment.
Source: nimh

NIH is funding a first-of-its-kind community-led research program to study ways to address the underlying structural factors within communities that affect health, such as access to safe spaces, healthy food, employment opportunities, transportation, and quality health care.
Source: nimh

Prenatal COVID-19 infection increased the risk for impaired attention and delayed socioemotional and cognitive functioning among infants of mothers who experienced high psychosocial stress during their pregnancy.
Source: nimh

This technical assistance webinar will be held for prospective applicants of the following Notice of Funding Opportunities (NOFOs): Approaches to Identifying Preteen Suicide Risk and Protective Factors (R01 Clinical Trial Not Allowed) and Data Coordinating Center for Approaches to Identifying Preteen Suicide Risk and Protective Factors (U24 Clinical Trial Not Allowed).
Source: nimh

During the annual meeting, this open session will feature research progress presentations from the Genes to Mental Health Network (G2MH) investigators.
Source: nimh

The Recovery After an Initial Schizophrenia Episode research initiative, launched by NIMH to test the effectiveness of coordinated specialty care to treat first-episode psychosis, has transformed the mental health landscape in the United States and helped thousands of people with schizophrenia achieve better outcomes.
Source: nimh

This webinar will explore the significance of involving community stakeholders in developing culturally responsive interventions, the need for implementation science to improve health care uptake in the Hispanic community, and the importance of bridging the gap between implementation science and health disparities research to reduce health inequities.
Source: nimh

This webinar will discuss the Research Domain Criteria (RDoC) initiative and its potential to inform (and be informed by) global mental health research.
Source: nimh